BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cecon E, Dam J, Luka M, Gautier C, Chollet AM, Delagrange P, Danober L, Jockers R. Quantitative assessment of oligomeric amyloid β peptide binding to α7 nicotinic receptor. Br J Pharmacol 2019;176:3475-88. [PMID: 30981214 DOI: 10.1111/bph.14688] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhong C, Akmentin W, Role LW, Talmage DA. Axonal α7* nicotinic acetylcholine receptors modulate glutamatergic signaling and synaptic vesicle organization in ventral hippocampal projections. Front Neural Circuits 2022;16:978837. [DOI: 10.3389/fncir.2022.978837] [Reference Citation Analysis]
2 Sinclair P, Kabbani N. Nicotinic receptor components of amyloid beta 42 proteome regulation in human neural cells. PLoS ONE 2022;17:e0270479. [DOI: 10.1371/journal.pone.0270479] [Reference Citation Analysis]
3 Cecon E, Oishi A, Luka M, Ndiaye-lobry D, François A, Panayi F, Dam J, Machado P, Jockers R. Novel repertoire of tau biosensors to monitor pathological tau transformation and seeding activity in living cells.. [DOI: 10.1101/2022.03.18.484918] [Reference Citation Analysis]
4 Li ZL, Gou CY, Wang WH, Li Y, Cui Y, Duan JJ, Chen Y. A novel effect of PDLIM5 in α7 nicotinic acetylcholine receptor upregulation and surface expression. Cell Mol Life Sci 2022;79:64. [PMID: 35013841 DOI: 10.1007/s00018-021-04115-y] [Reference Citation Analysis]
5 Letsinger AC, Gu Z, Yakel JL. α7 nicotinic acetylcholine receptors in the hippocampal circuit: taming complexity. Trends Neurosci 2021:S0166-2236(21)00235-6. [PMID: 34916082 DOI: 10.1016/j.tins.2021.11.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
6 Madhu P, Mukhopadhyay S. Distinct types of amyloid-β oligomers displaying diverse neurotoxicity mechanisms in Alzheimer's disease. J Cell Biochem 2021;122:1594-608. [PMID: 34494298 DOI: 10.1002/jcb.30141] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
7 Gasiorowska A, Wydrych M, Drapich P, Zadrozny M, Steczkowska M, Niewiadomski W, Niewiadomska G. The Biology and Pathobiology of Glutamatergic, Cholinergic, and Dopaminergic Signaling in the Aging Brain. Front Aging Neurosci 2021;13:654931. [PMID: 34326765 DOI: 10.3389/fnagi.2021.654931] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 14.0] [Reference Citation Analysis]
8 Pismataro MC, Horenstein NA, Stokes C, Dallanoce C, Thakur GA, Papke RL. Stable desensitization of α7 nicotinic acetylcholine receptors by NS6740 requires interaction with S36 in the orthosteric agonist binding site. Eur J Pharmacol 2021;905:174179. [PMID: 34004208 DOI: 10.1016/j.ejphar.2021.174179] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Anni D, Weiss EM, Guhathakurta D, Akdas YE, Klueva J, Zeitler S, Andres-Alonso M, Huth T, Fejtova A. Aβ1-16 controls synaptic vesicle pools at excitatory synapses via cholinergic modulation of synapsin phosphorylation. Cell Mol Life Sci 2021;78:4973-92. [PMID: 33864480 DOI: 10.1007/s00018-021-03835-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
10 Wu J, Cao C, Loch RA, Tiiman A, Luo J. Single-molecule studies of amyloid proteins: from biophysical properties to diagnostic perspectives. Q Rev Biophys 2020;53:e12. [PMID: 33148356 DOI: 10.1017/S0033583520000086] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
11 Duce JA, Zhu X, Jacobson LH, Beart PM. Therapeutics for dementia and Alzheimer's disease: New directions for precision medicine. Br J Pharmacol 2019;176:3409-12. [PMID: 31468515 DOI: 10.1111/bph.14767] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
12 Huang YR, Liu RT. The Toxicity and Polymorphism of β-Amyloid Oligomers. Int J Mol Sci 2020;21:E4477. [PMID: 32599696 DOI: 10.3390/ijms21124477] [Cited by in Crossref: 32] [Cited by in F6Publishing: 38] [Article Influence: 16.0] [Reference Citation Analysis]
13 Potasiewicz A, Krawczyk M, Gzielo K, Popik P, Nikiforuk A. Positive allosteric modulators of alpha 7 nicotinic acetylcholine receptors enhance procognitive effects of conventional anti-Alzheimer drugs in scopolamine-treated rats. Behavioural Brain Research 2020;385:112547. [DOI: 10.1016/j.bbr.2020.112547] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
14 Sun JL, Stokoe SA, Roberts JP, Sathler MF, Nip KA, Shou J, Ko K, Tsunoda S, Kim S. Co-activation of selective nicotinic acetylcholine receptors is required to reverse beta amyloid-induced Ca2+ hyperexcitation. Neurobiol Aging 2019;84:166-77. [PMID: 31629115 DOI: 10.1016/j.neurobiolaging.2019.09.005] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 5.7] [Reference Citation Analysis]
15 Cecon E, Dam J, Luka M, Gautier C, Chollet AM, Delagrange P, Danober L, Jockers R. Quantitative assessment of oligomeric amyloid β peptide binding to α7 nicotinic receptor. Br J Pharmacol 2019;176:3475-88. [PMID: 30981214 DOI: 10.1111/bph.14688] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]